These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26646751)

  • 41. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial.
    McKenzie R; O'Fallon A; Dale J; Demitrack M; Sharma G; Deloria M; Garcia-Borreguero D; Blackwelder W; Straus SE
    JAMA; 1998 Sep 23-30; 280(12):1061-6. PubMed ID: 9757853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study.
    Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Ragnarsson O; Skrtic S; Wahlberg J; Achenbach H; Uddin S; Marelli C; Johannsson G
    Eur J Endocrinol; 2017 Jun; 176(6):715-725. PubMed ID: 28292927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An observational study on adrenal insufficiency in a French tertiary centre: Real life versus theory.
    Castinetti F; Sahnoun M; Albarel F; Morange I; Philippon M; Conte-Devolx B; Brue T
    Ann Endocrinol (Paris); 2015 Feb; 76(1):1-8. PubMed ID: 25617904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis.
    Schramm C; Wahl I; Weiler-Normann C; Voigt K; Wiegard C; Glaubke C; Brähler E; Löwe B; Lohse AW; Rose M
    J Hepatol; 2014 Mar; 60(3):618-24. PubMed ID: 24240053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How well do randomized controlled trial data generalize to 'real-world' clinical practice settings? A comparison of two generalized anxiety disorder studies.
    Kasper S; Brasser M; Schweizer E; Lyndon G; Prieto R
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):125-32. PubMed ID: 24290532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the frequency of adrenal crises and preventive measures in patients with primary and secondary adrenal insufficiency in Switzerland.
    Notter A; Jenni S; Christ E
    Swiss Med Wkly; 2018; 148():w14586. PubMed ID: 29376554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial.
    Binder G; Weber S; Ehrismann M; Zaiser N; Meisner C; Ranke MB; Maier L; Wudy SA; Hartmann MF; Heinrich U; Bettendorf M; Doerr HG; Pfaeffle RW; Keller E;
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1182-90. PubMed ID: 19126625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relative adrenal insufficiency among trauma patients in a community hospital.
    Beeman BR; Veverka TJ; Lambert P; Boysen DM
    Curr Surg; 2005; 62(6):633-7. PubMed ID: 16293500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impaired health-related quality of life in Addison's disease--impact of replacement therapy, comorbidities and socio-economic factors.
    Kluger N; Matikainen N; Sintonen H; Ranki A; Roine RP; Schalin-Jäntti C
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):511-8. PubMed ID: 24801591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency.
    Nilsson AG; Marelli C; Fitts D; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Lennernäs H; Skrtic S; Johannsson G
    Eur J Endocrinol; 2014 Sep; 171(3):369-77. PubMed ID: 24944332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GLUCOCORTICOID REPLACEMENT REGIMENS IN CHRONIC ADRENAL INSUFFICIENCY: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Al Nofal A; Bancos I; Benkhadra K; Ospina NM; Javed A; Kapoor E; Muthusamy K; Brito JP; Turcu AF; Wang Z; Prokop L; Erickson DZ; Lteif AN; Natt N; Murad MH
    Endocr Pract; 2017 Jan; 23(1):17-31. PubMed ID: 27631672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
    Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
    Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
    Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Higher hydrocortisone dose increases bilirubin in hypopituitary patients- results from an RCT.
    Werumeus Buning J; Kootstra-Ros JE; Brummelman P; van den Berg G; van der Klauw M; Wolffenbuttel BH; van Beek AP; Dullaart RP
    Eur J Clin Invest; 2016 May; 46(5):475-80. PubMed ID: 26999644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
    Langley RG; Feldman SR; Han C; Schenkel B; Szapary P; Hsu MC; Ortonne JP; Gordon KB; Kimball AB
    J Am Acad Dermatol; 2010 Sep; 63(3):457-65. PubMed ID: 20462664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of lifetime mood and panic-agoraphobic spectrum symptoms on quality of life of patients with rheumatoid arthritis.
    Piccinni A; Maser JD; Bazzichi L; Rucci P; Vivarelli L; Del Debbio A; Catena M; Bombardieri S; Dell'Osso L
    Compr Psychiatry; 2006; 47(3):201-8. PubMed ID: 16635649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Self-management in adrenal insufficiency - towards a better understanding.
    Kampmeyer D; Haas CS; Moenig H; Harbeck B
    Endocr J; 2017 Apr; 64(4):379-385. PubMed ID: 28190868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dehydroepiandrosterone replacement in women with adrenal insufficiency.
    Arlt W; Callies F; van Vlijmen JC; Koehler I; Reincke M; Bidlingmaier M; Huebler D; Oettel M; Ernst M; Schulte HM; Allolio B
    N Engl J Med; 1999 Sep; 341(14):1013-20. PubMed ID: 10502590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.
    Loftus EV; Feagan BG; Colombel JF; Rubin DT; Wu EQ; Yu AP; Pollack PF; Chao J; Mulani P
    Am J Gastroenterol; 2008 Dec; 103(12):3132-41. PubMed ID: 18853973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.